Comparison of Two High-Dose Magnesium Infusion Regimens in the Treatment of Status Asthmaticus
- PMID: 27453701
- PMCID: PMC4956331
- DOI: 10.5863/1551-6776-21.3.233
Comparison of Two High-Dose Magnesium Infusion Regimens in the Treatment of Status Asthmaticus
Abstract
Objectives: To determine the feasibility and safety of a simplified high-dose magnesium sulfate infusion (sHDMI) for the treatment of status asthmaticus.
Methods: We retrospectively compared 2 different high-dose magnesium sulfate infusion regimens, as adjunctive treatment in status asthmatics, using data that were preciously collected. The initial high-dose, prolonged magnesium infusion (HDMI) regimen consisted of a loading dose of 75 mg/kg (weight ≤ 30 kg) or 50 mg/kg (weight > 30 kg) over a period of 30 to 45 minutes followed by a continuous infusion of 40 mg/kg/hr for an additional 4 hours. This was compared to the sHDMI regimen that consisted of 50 mg/kg/hr for 5 hours. No loading dose was given to the patients in the sHDMI arm. Obese patients were dosed by using ideal body weight. Physiologic parameters (i.e., heart rate, blood pressure, respiratory rate, oxygen saturation) and serum magnesium (SrMg) concentrations were monitored during administration of magnesium sulfate.
Results: Nineteen patients receiving the initial HDMI regimen were compared with 10 patients who received the sHDMI regimen. There was no significant difference in SrMg concentrations or physiologic parameters between the 2 dose regimens.
Conclusions: The HDMI and sHDMI regimens both produced SrMg concentrations that are associated with bronchodilation. The safety profile was also similar for the 2 regimens. The unambiguity of sHDMI has the potential to reduce medication errors that are associated with calculation of the loading dose, product preparation, and ultimate administration.
Keywords: asthma; infusion; magnesium sulfate; pediatric; status asthmaticus.
Figures



References
-
- Carroll CL, Sala KA. Pediatric status asthmaticus. Crit Care Clin. 2013;29(2):153–166. - PubMed
-
- Guill MF. Asthma update: epidemiology and pathophysiology. Pediatr Rev. 2004;25(9):299–305. - PubMed
-
- Yoshioka H, Hirota K, Sato T et al. Spasmolytic effect of magnesium sulfate on serotonin-induced pulmonary hypertension and bronchoconstriction in dogs. Acta Anaesthesiol Scand. 2001;45(4):435–440. - PubMed
-
- Egelund TA, Wassil SK, Edwards EM et al. High-dose magnesium sulfate infusion protocol for status asthmaticus: a safety and pharmacokinetics cohort study. Intensive Care Med. 2013;39(1):117–122. - PubMed